Sabrina Cuddy • June 28, 2023
July is about COE Care at the HCMA

What is a Center of Excellence (COE)? 

A Center of Excellence is a team of specialists who come together to provide high-quality care to patients with a specific disease using accepted best practices. It is common for medical facilities to seek COE status if they have a team working with a particular disease, such as Cancer, Diabetes, Alzheimer’s, or, of course, HCM.

The HCMA created the “HCMA Recognized Centers of Excellence” program in 2004. This program ensures that the services and procedures offered at recognized COEs align with current best practices for managing patients with HCM. Centers must use a team approach to care, including HCM specialist cardiologists, genetic counselors, imaging specialists, and more. In addition, a COE has up-to-date equipment and scanning protocols, with technicians trained to get the right angles during your testing. 

The American Heart Association and the American College of Cardiologists support this model of care in their best practice guidelines for HCM, 2020. 

For a list of centers, please visit our website at  https://4hcm.org/center-of-excellence/. You can also see the criteria used in the review of these programs. We currently recognize COEs in the United States, but we can often recommend somewhere for you to go if you are in another country – please contact us for more information. The HCMA continues to grow new programs and evaluate them for COE status. We want you to have COE care near your home.

We also offer need-based travel grants to help people get the best care for HCM. Call us at 973-983-7429 and ask about the Lori Fund, or apply on our website.  https://secure.4hcm.org/forms/lori-fund-scholarship   The Lori Fund can reimburse you for gas, airfare, hotel, and food up to $600 annually to help you get to a Center of Excellence. 

HCMA Blog

By Sabrina Cuddy July 3, 2025
By Erica Friedman June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
A light blue and dark blue paintbrush stroke intersect to make a stylized
By Erica Friedman June 18, 2025
Alnylam press release on the European Commission approval of AMVUTTRA® (vutrisiran) forwild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM) as an additional indication
More Posts